Cargando…

Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss

Background: Recurrent pregnancy loss (RPL) caused by various genetic and non-genetic factors. After chromosome abnormality, thrombophilia is one of the most important genetic factors that could cause RPL. Factor V Leiden and factor II G20210A mutation were the most common mutations cause thrombophil...

Descripción completa

Detalles Bibliográficos
Autores principales: Teremmahi Ardestani, Majid, Nodushan, Hossein Hadi, Aflatoonian, Abbas, Ghasemi, Nasrin, Sheikhha, Mohammad Hasan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research and Clinical Center for Infertility 2013
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941375/
https://www.ncbi.nlm.nih.gov/pubmed/24639694
_version_ 1782305907129974784
author Teremmahi Ardestani, Majid
Nodushan, Hossein Hadi
Aflatoonian, Abbas
Ghasemi, Nasrin
Sheikhha, Mohammad Hasan
author_facet Teremmahi Ardestani, Majid
Nodushan, Hossein Hadi
Aflatoonian, Abbas
Ghasemi, Nasrin
Sheikhha, Mohammad Hasan
author_sort Teremmahi Ardestani, Majid
collection PubMed
description Background: Recurrent pregnancy loss (RPL) caused by various genetic and non-genetic factors. After chromosome abnormality, thrombophilia is one of the most important genetic factors that could cause RPL. Factor V Leiden and factor II G20210A mutation were the most common mutations cause thrombophilia in the world. Objective: The purpose of this study was to determine the frequency of factor V Leiden and prothrombine gene mutations in women with RPL compared with women who had uneventful pregnancies. Materials and Methods: This case control study evaluates the frequency of factor V-Leiden and factor II G20210 genotypes in 80 women with two or more pregnancy losses, compared with 80 women without adverse pregnancy outcome. The mutations were assessed by PCR-RFLP. Results: Frequency of the factor V Leiden among cases was 2.5%, which was higher than controls (1.25%), but the difference was not significant. No factor II G20210 mutation was found among cases and controls. Conclusion: These data did not confirm that factor V Leiden and factor II G20210 mutation might play a role in recurrent pregnancy loss in Iranian women.
format Online
Article
Text
id pubmed-3941375
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Research and Clinical Center for Infertility
record_format MEDLINE/PubMed
spelling pubmed-39413752014-03-17 Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss Teremmahi Ardestani, Majid Nodushan, Hossein Hadi Aflatoonian, Abbas Ghasemi, Nasrin Sheikhha, Mohammad Hasan Iran J Reprod Med Background: Recurrent pregnancy loss (RPL) caused by various genetic and non-genetic factors. After chromosome abnormality, thrombophilia is one of the most important genetic factors that could cause RPL. Factor V Leiden and factor II G20210A mutation were the most common mutations cause thrombophilia in the world. Objective: The purpose of this study was to determine the frequency of factor V Leiden and prothrombine gene mutations in women with RPL compared with women who had uneventful pregnancies. Materials and Methods: This case control study evaluates the frequency of factor V-Leiden and factor II G20210 genotypes in 80 women with two or more pregnancy losses, compared with 80 women without adverse pregnancy outcome. The mutations were assessed by PCR-RFLP. Results: Frequency of the factor V Leiden among cases was 2.5%, which was higher than controls (1.25%), but the difference was not significant. No factor II G20210 mutation was found among cases and controls. Conclusion: These data did not confirm that factor V Leiden and factor II G20210 mutation might play a role in recurrent pregnancy loss in Iranian women. Research and Clinical Center for Infertility 2013-01 /pmc/articles/PMC3941375/ /pubmed/24639694 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Teremmahi Ardestani, Majid
Nodushan, Hossein Hadi
Aflatoonian, Abbas
Ghasemi, Nasrin
Sheikhha, Mohammad Hasan
Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss
title Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss
title_full Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss
title_fullStr Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss
title_full_unstemmed Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss
title_short Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss
title_sort case control study of the factor v leiden and factor ii g20210a mutation frequency in women with recurrent pregnancy loss
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941375/
https://www.ncbi.nlm.nih.gov/pubmed/24639694
work_keys_str_mv AT teremmahiardestanimajid casecontrolstudyofthefactorvleidenandfactoriig20210amutationfrequencyinwomenwithrecurrentpregnancyloss
AT nodushanhosseinhadi casecontrolstudyofthefactorvleidenandfactoriig20210amutationfrequencyinwomenwithrecurrentpregnancyloss
AT aflatoonianabbas casecontrolstudyofthefactorvleidenandfactoriig20210amutationfrequencyinwomenwithrecurrentpregnancyloss
AT ghaseminasrin casecontrolstudyofthefactorvleidenandfactoriig20210amutationfrequencyinwomenwithrecurrentpregnancyloss
AT sheikhhamohammadhasan casecontrolstudyofthefactorvleidenandfactoriig20210amutationfrequencyinwomenwithrecurrentpregnancyloss